Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0371115B2 - - Google Patents
[go: Go Back, main page]

JPH0371115B2 - - Google Patents

Info

Publication number
JPH0371115B2
JPH0371115B2 JP25431490A JP25431490A JPH0371115B2 JP H0371115 B2 JPH0371115 B2 JP H0371115B2 JP 25431490 A JP25431490 A JP 25431490A JP 25431490 A JP25431490 A JP 25431490A JP H0371115 B2 JPH0371115 B2 JP H0371115B2
Authority
JP
Japan
Prior art keywords
plasmid
pta5001
restriction enzyme
added
xho
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP25431490A
Other languages
Japanese (ja)
Other versions
JPH03151881A (en
Inventor
Hajime Okumura
Takeshi Uozumi
Teruhiko Betsupu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58116149A external-priority patent/JPS609488A/en
Application filed by Individual filed Critical Individual
Priority to JP25431490A priority Critical patent/JPH03151881A/en
Publication of JPH03151881A publication Critical patent/JPH03151881A/en
Publication of JPH0371115B2 publication Critical patent/JPH0371115B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発明は酢酸菌ベクターとしてきわめて有用な
プラスミドpTA5001(B)に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to plasmid pTA5001(B), which is extremely useful as an acetic acid bacterium vector.

更に詳細には、本発明は、制限酵素Xhoによ
る認識部位をただ1ケ所有し、かつ酢酸菌への移
入が容易なプラスミドpTA5001(B)に関するもの
である。
More specifically, the present invention relates to plasmid pTA5001(B), which possesses only one recognition site for the restriction enzyme Xho and is easily transferred to acetic acid bacteria.

従来、酢酸菌由来のプラスミドに関しては、ア
セトバクター・アセチNo.1023が分子量17×106
ルトンのプラスミドpTA5001(Agric.Biol.
Chem.46(2)、381〜389、1982)を持つこと及び
グルコノバクター属細菌(醗酵工学雑誌、61
(1)、15−18、1983)の持つプラスミドなどの報
告があつた。
Conventionally, regarding plasmids derived from acetic acid bacteria, Acetobacter aceti No. 1023 has a molecular weight of 17 × 10 6 daltons, plasmid pTA5001 (Agric.Biol.
Chem.46(2), 381-389, 1982) and Gluconobacter bacteria (Fermentation Engineering Journal, 61
(1), 15-18, 1983) were reported.

本発明者らは、このプラスミドpTA5001を詳
細に研究したところ、実際は2ケのプラスミドの
混在物であることを知り、更に2ケのプラスミド
の制限酵素開裂地図の作成を完成させ、その用途
を詳細に検討したところ、いずれのプラスミドも
制限酵素Xhoによる認識部位をただ1ケ所有
し、かつ酢酸菌への移入の容易なすぐれたベクタ
ーであることを確認し、本発明を完成するに至つ
た。
After studying this plasmid pTA5001 in detail, the present inventors learned that it was actually a mixture of two plasmids, and completed the creation of a restriction enzyme cleavage map for the two plasmids and detailed its use. Upon investigation, it was confirmed that each plasmid possesses only one recognition site by the restriction enzyme Xho and is an excellent vector that can be easily transferred into acetic acid bacteria, leading to the completion of the present invention.

本発明は22.5Kbの分子量で、第2図の制限酵
素開裂地図で示されるプラスミドpTA5001(B)に
関する。
The present invention relates to plasmid pTA5001(B), which has a molecular weight of 22.5 Kb and is shown in the restriction enzyme cleavage map of FIG.

本発明のプラスミドpTA5001(B)とプラスミド
pTA5001(A)は同時にアセトバクター・アセチNo.
1023に存在し、該菌よりまず両者の混在物として
分離することができる。
Plasmid pTA5001(B) of the present invention and plasmid
pTA5001(A) is also Acetobacter aceti No.
1023, and can be isolated from this bacterium as a mixture of both.

アセトバクター・アセチNo.1023は酢酸醗酵醪か
ら単離・同定されたものであり(Agric.Biol.
Chem.,44(12),2901〜2906,1980)、プラスミ
ドpTA5001(A)及びプラスミドpTA5001(B)を含ん
だまま微工研にFERM P−7122として寄託され
ている。
Acetobacter aceti No. 1023 was isolated and identified from acetic acid fermentation mash (Agric.Biol.
Chem., 44(12), 2901-2906, 1980), and has been deposited as FERM P-7122 at FIKEN, containing plasmid pTA5001(A) and plasmid pTA5001(B).

アセトバクター・アセチNo.1023は菌学的性質に
おいてバージイ第8版のアセトバクター・アセチ
の菌学的性質の記載とよく一致し、更に酢酸耐性
及びエタノール酸化能を有することで特徴的であ
り、Acetobacter aceti No.1023(Acer,Eth++
と表示されることもある。
The mycological properties of Acetobacter aceti No. 1023 closely match the description of the mycological properties of Acetobacter aceti in the 8th edition of Virgil, and it is further characterized by having acetic acid resistance and ethanol oxidation ability. Acetobacter aceti No.1023 (Ace r , Eth ++ )
may also be displayed.

アセトバクター・アセチNo.1023は、例えば通常
的には下記のYPG培地で培養され、また形質転
換株の検出にはYPG培地に抗生物質等の薬剤を
適当な濃度となるように、例えばアンピシリンを
50μg/mlの濃度となるように、添加したものを
用いて培養される。
Acetobacter aceti No. 1023 is usually cultured in the following YPG medium, for example, and to detect transformed strains, the YPG medium is supplemented with drugs such as antibiotics to an appropriate concentration, such as ampicillin.
The cells are cultured using the added material at a concentration of 50 μg/ml.

(YPG培地) イースト エキストラクト 0.5% ポリペプトン 0.2% グルコース 3.0% 寒天(固体培地の場合) 2.0% PH=6.5 アセトバクター・アセチNo.1023はYPG液体培
地で、30℃で24〜36時間振とう培養し、培養液を
遠心分離処理して集菌される。菌体は緩衝液で十
分洗浄し、緩衝液に懸濁され、これにリゾチーム
が添加され、溶菌される。溶菌液には界面活性剤
及び食塩が添加され、静置後遠心分離し、上清に
ポリエチンレングリコールが添加され、静置後遠
心分離し沈殿物を得る。この沈澱物を緩衝液に溶
解し、エチジウムブロマイドを加え、更に塩化セ
シウムを加え、密度を1.57に合わせ、密度勾配遠
心分離を行こなう。遠心分離後、遠心チユーブに
紫外線ランプで365nmの紫外線照射により、染色
体バンドの下に出たバンドを分取する。
(YPG medium) Yeast extract 0.5% Polypeptone 0.2% Glucose 3.0% Agar (in the case of solid medium) 2.0% PH = 6.5 Acetobacter aceti No. 1023 was cultured in YPG liquid medium with shaking at 30℃ for 24 to 36 hours. Then, the culture solution is centrifuged to collect bacteria. The bacterial cells are thoroughly washed with a buffer solution, suspended in the buffer solution, lysozyme is added thereto, and the cells are lysed. A surfactant and salt are added to the lysate, and after being allowed to stand, it is centrifuged. Polyethylene glycol is added to the supernatant, and after being allowed to stand, it is centrifuged to obtain a precipitate. This precipitate is dissolved in a buffer solution, ethidium bromide is added, cesium chloride is further added, the density is adjusted to 1.57, and density gradient centrifugation is performed. After centrifugation, the centrifugation tube is irradiated with 365 nm ultraviolet light using an ultraviolet lamp to separate the band that appears below the chromosome band.

ここで得られるバンドにはプラスミド
pTA5001(A)とプラスミドpTA5001(B)が混在して
いる。
The band obtained here contains plasmid
pTA5001(A) and plasmid pTA5001(B) are mixed.

混在する2つのプラスミドは制限酵素による解
析の結果、はじめて2種類のほぼ同一分子量のプ
ラスミドの混在物であることが明らかとなつたも
のである。
As a result of restriction enzyme analysis, it was revealed for the first time that the two mixed plasmids were a mixture of two types of plasmids with approximately the same molecular weight.

プラスミドpTA5001(B)の分子量は22.5Kbで、
制限酵素開裂地図は第2図に示される。
The molecular weight of plasmid pTA5001(B) is 22.5Kb,
The restriction enzyme cleavage map is shown in FIG.

図面に示される略記号の意味は次の通りであ
る。
The meanings of the abbreviations shown in the drawings are as follows.

E:EcoR:Escherichia coli RY13 給源の制限酵素 S:Sal:Streptomyces albus G 給源の制限酵素 X:Xho:Xanthomonas holcicola 給源の制限酵素 本発明のプラスミドpTA5001(B)はXhoによ
つてただ1ケ所のみ切断されることによつてきわ
めて特徴的であつて、この切断部位に他のプラス
ミド断片や染色体断片を導入するのがきわめて容
易である。
E: EcoR: Escherichia coli RY13 source restriction enzyme S: Sal: Streptomyces albus G source restriction enzyme X: Xho: Xanthomonas holcicola source restriction enzyme Plasmid pTA5001(B) of the present invention is cleaved at only one site by Xho This cleavage site is very characteristic, and it is extremely easy to introduce other plasmid fragments or chromosomal fragments into this cleavage site.

本発明のプラスミドpTA5001(B)は酢酸菌ベク
ターとして使用するのに好適である。
Plasmid pTA5001(B) of the present invention is suitable for use as an acetic acid bacterium vector.

即ち、プラスミドpTA5001(B)にプラスミド断
片又は染色体断片を導入したものは、酢酸菌(ア
セトバクター属菌、グルコノバクター属菌)に容
易に移入することができ、酢酸菌の形質転換及
び/又は物質生産に新たな画期的手法を提供する
ものである。
That is, the plasmid pTA5001(B) into which a plasmid fragment or chromosome fragment has been introduced can be easily transferred to acetic acid bacteria (Acetobacter spp., Gluconobacter spp.), and can be used for transformation and/or It provides a new and innovative method for material production.

次に本発明の実施例を示す。 Next, examples of the present invention will be shown.

実施例1、DNA受容菌体の調製 アセトバクター・アセチNo.1023,FERM P−
7122より100μg/ml濃度のニトロソグアニジン
(NTG)変異処理によつて得られたプロリン要求
性(Pro-)の親株であるアセトバクター・アセ
チ10−8(Acer,Eth++,Pro-)から自然変異に
よつて得た酢酸耐性およびエタノール酸化能が低
下、欠失(Acess,Eth-)し、かつ、ストレプト
マイシン耐性(Strr)の菌株であるアセトバクタ
ー・アセチ10−80S1(Acess,Eth-,Pro-,Strr
を500ml坂口フラスンコに入れた100mlYPG液体
培地に接種し、30℃で20時間振とう培養した。
Example 1, Preparation of DNA receptor cells Acetobacter aceti No. 1023, FERM P-
From Acetobacter aceti 10-8 ( Acer , Eth ++ , Pro - ), a proline auxotrophic (Pro - ) parent strain obtained from 7122 by mutation treatment with nitrosoguanidine (NTG) at a concentration of 100 μg/ml. Acetobacter aceti 10-80S1 (Ace ss , Eth - ), a strain with streptomycin resistance (Str r ), has reduced or deleted acetic acid tolerance and ethanol oxidation ability (Ace ss , Eth - ) obtained through natural mutation. Eth- , Pro- , Str r )
was inoculated into 100 ml YPG liquid medium in a 500 ml Sakaguchi flask, and cultured with shaking at 30°C for 20 hours.

培養液は0℃で、6000×gで、10分間遠心分離
し、集菌する。菌体は100mM NaCl及び5mM
MgCl2を含有する5mMトリス塩酸緩衝液(PH
7.6)の0.5倍容量で2回洗滌する。再び0℃で
6000×gで、5分間遠心分離し、集菌する。
The culture solution is centrifuged at 0° C. and 6000×g for 10 minutes to collect bacteria. Bacterial cells are 100mM NaCl and 5mM
5mM Tris-HCl buffer (PH
Wash twice with 0.5 times the volume of 7.6). again at 0℃
Centrifuge at 6000 xg for 5 minutes to collect bacteria.

この菌体には0.4倍容量のCaCl2溶液
(100mMCaCl2,250mM KCl,5mM MgCl2
5mM Tris−HCl,PH7.6)が加えられ、0℃で
30分間静置した後0℃で、6000×gで、5分間遠
心分離し、集菌する。
This bacterial cell was mixed with 0.4 times the volume of CaCl2 solution ( 100mMCaCl2 , 250mM KCl, 5mM MgCl2 ,
5mM Tris-HCl, PH7.6) was added and incubated at 0°C.
After standing for 30 minutes, centrifuge at 0°C and 6000 xg for 5 minutes to collect bacteria.

菌体には0.004倍容量の上記CaCl2溶液を添加し
DNA受容菌体懸濁液とした。
Add 0.004 times the volume of the above CaCl 2 solution to the bacterial cells.
A DNA receptor cell suspension was prepared.

実施例2、プラスミドpTA5001(B)とプラスミド
pTA5001(A)の混在物の単離 アセトバクター・アセチNo.1023,FERM P−
7122を40mlのYPG培地に植菌し、30℃で一晩振
とう培養した。
Example 2, plasmid pTA5001(B) and plasmid
Isolation of pTA5001(A) contaminants Acetobacter aceti No.1023, FERM P-
7122 was inoculated into 40 ml of YPG medium and cultured with shaking at 30°C overnight.

その後新らしいYPG培地4に1%で植え継
ぎさらに30℃で36時間振とう培養した。
Thereafter, it was subcultured to a new YPG medium 4 at a concentration of 1% and further cultured with shaking at 30°C for 36 hours.

集菌後、TE緩衝液(20mM EDTA,50mM
トリス塩酸、PH8.0)で2回菌体を洗浄した。
After bacterial collection, add TE buffer (20mM EDTA, 50mM
The bacterial cells were washed twice with Tris-HCl (pH 8.0).

得られた湿菌体2gあたり2mlのTES緩衝液
(50mM トリス塩酸、20mM EDTA、25%シヨ
糖、PH8.0)を加え、菌体を懸濁し、4mlのリゾ
チーム液(0.25M トリス塩酸、リゾチーム2
%、PH8.0)をさらに加え、0℃で5分間静置し
た。次に0.25MEDTA液(PH8.0)を4ml加え、
0℃で5分間静置した後、37℃で20分間反応させ
た。反応後、3mlの10%ラウリル硫酸ナトリウム
を加え、37℃で20分間静置後、5mlの5M食塩水
を加え、0℃で一夜静置した。48200×gで60分
間遠心分離をかけ、上清を分取した。次にこの上
清に最終濃度で10%になるようにポリエチレング
リコール6000を加え、4℃で一夜静置した後、
3000×gで10分間遠心分離し、沈澱物を得た。こ
の沈澱物を7mlのUC緩衝液(50mM トリス塩
酸、5mM EDTA,50mM NaCl,PH7.8)に溶
解させた後、最終濃度で500μg/mlになるよう
にエチジウムブロマイドを加え、さらに塩化セシ
ウムを加えて密度を1.57に合わせた。この溶液を
15℃、100200×gで40時間密度勾配遠心分離をお
こなつた。遠心分離後、遠心チユーブに紫外線ラ
ンプで365nmの紫外線を照射することにより、染
色体バンドの下にあらわれるバンドをプラスミド
分画として分取した。次いで、分画液をイソプロ
パノールで処理し、エチジウムブロマイドを除去
した後、TE緩衝液(10mM トリス塩酸、1mM
EDTA,PH7.5)に対して透析した。これをプラ
スミド混在溶液とした。
Add 2ml of TES buffer (50mM Tris-HCl, 20mM EDTA, 25% sucrose, PH8.0) per 2g of the obtained wet bacterial cells to suspend the cells, and add 4ml of lysozyme solution (0.25M Tris-HCl, lysozyme). 2
%, PH8.0) was further added, and the mixture was allowed to stand at 0°C for 5 minutes. Next, add 4ml of 0.25MEDTA solution (PH8.0),
After standing at 0°C for 5 minutes, the mixture was reacted at 37°C for 20 minutes. After the reaction, 3 ml of 10% sodium lauryl sulfate was added and left to stand at 37°C for 20 minutes, then 5 ml of 5M saline was added and left to stand at 0°C overnight. Centrifugation was performed at 48,200×g for 60 minutes, and the supernatant was collected. Next, polyethylene glycol 6000 was added to this supernatant to a final concentration of 10%, and after standing at 4°C overnight,
Centrifugation was performed at 3000×g for 10 minutes to obtain a precipitate. After dissolving this precipitate in 7ml of UC buffer (50mM Tris-HCl, 5mM EDTA, 50mM NaCl, PH7.8), ethidium bromide was added to a final concentration of 500μg/ml, and then cesium chloride was added. The density was adjusted to 1.57. This solution
Density gradient centrifugation was performed at 15° C. and 100,200×g for 40 hours. After centrifugation, the centrifugation tube was irradiated with 365 nm ultraviolet light using an ultraviolet lamp, and the band appearing below the chromosome band was separated as a plasmid fraction. The fractionated solution was then treated with isopropanol to remove ethidium bromide, and then treated with TE buffer (10mM Tris-HCl, 1mM
Dialysis was performed against EDTA, pH 7.5). This was used as a plasmid mixed solution.

得られたプラスミド混在溶液中には2つの環状
プラスミドが混在しており、制限酵素による解析
の結果、第1図に示すプラスミドpTA5001(A)と
第2図に示すプラスミドpTA5001(B)であること
が明らかとなつた。
Two circular plasmids were found mixed in the resulting plasmid mixed solution, and as a result of analysis using restriction enzymes, it was determined that the plasmids were pTA5001(A) shown in Figure 1 and plasmid pTA5001(B) shown in Figure 2. It became clear.

すなわち前記で調製したプラスミド混在溶液に
対し、少なくとも5倍量過剰の制限酵素(EcoR
およびSalは宝酒造社製、Xhoは、ベセス
ダ・リサーチ社製を使用した。)を常法に従がつ
て各々の制限酵素の至適条件下で反応させた。反
応後、垂直型アガロースゲル電気泳動で分析し
た。即ち、1%アガロースゲルを用い、トリス酢
酸緩衝液(40mM トリス、20mM酢酸、2mM
EDTA,PH8.1)中で泳動させた。その後、ゲル
をエチジウムブロマイドの1μg/mlに浸して染
色した。このゲルに紫外線を照射し、生成断片の
数を判定し、各断片の泳動距離から、各々の分子
量を算出した。分子量は、同一アガロース上で同
時に泳動したラムダフアージDNAのHind切断
で生成する分子量既知の各断片の泳動距離から作
成した標準線をもとに算出した。
That is, at least a 5-fold excess of restriction enzyme (EcoR) was added to the plasmid mixed solution prepared above.
and Sal were manufactured by Takara Shuzo, and Xho was manufactured by Bethesda Research. ) were reacted according to a conventional method under optimal conditions for each restriction enzyme. After the reaction, it was analyzed by vertical agarose gel electrophoresis. That is, using a 1% agarose gel, Tris acetate buffer (40mM Tris, 20mM acetic acid, 2mM
Electrophoresis was performed in EDTA, pH 8.1). The gel was then stained with 1 μg/ml ethidium bromide. This gel was irradiated with ultraviolet rays, the number of generated fragments was determined, and the molecular weight of each fragment was calculated from the migration distance of each fragment. The molecular weight was calculated based on a standard line created from the migration distance of each fragment of known molecular weight generated by Hind cleavage of lambda phage DNA that was electrophoresed simultaneously on the same agarose.

各種制限酵素を単独で用いて得られた各断片及
び各制限酵素の2種以上を組合わせて用いた処理
によつて得られた各断片の断片数及び分子量など
からpTA5001(A)及びpTA5001(B)の第1図及び第
2図に示した制限酵素開裂地図が決定された。
pTA5001(A) and pTA5001( The restriction enzyme cleavage map shown in Figures 1 and 2 of B) was determined.

実施例3、プラスミドpTA5001(A)とプラスミド
pTA5001(B)の混在物のベクターと
しての利用 実施例2で得られたプラスミド混在溶液
(DNA量10μg)中に、大腸菌薬剤耐性ベクター
であるpACYC177(カナマイシン耐性及びアンピ
シリン耐性;Journal of Bacteriology,134
(3),1141−1156,1978)を持つ大腸菌
(Escherichia coli C600)から得たプラスミド
pACYC177(第3図に示す。DNA量2μg)を添
加し少なくとも5倍量過剰の制限酵素Xhoを常
法により至適条件下で反応させ、反応終了後、等
量のフエノールを加え、激しく攪拌して制限酵素
を失活させた後、さらにエーテル抽出を充分行な
つてフエノールを除去し、さらに2倍量のエタノ
ールを加えて−80℃に1時間保持した後、
15000rpmで5分間遠心分離を行なつてDNAを沈
降させ、さらに真空乾燥してエタノールを除去し
た後、次に沈澱を水に溶解後、常法によつてT4
DNA リガーゼによる反応を21℃で2時間行な
い、さらに前記と同様にしてエタノール沈澱、真
空乾燥を行なつて得られた沈澱をTE緩衝液0.1ml
に溶解してキメラプラスミド含有溶液を得た。
Example 3, plasmid pTA5001(A) and plasmid
Use of pTA5001(B) as a vector In the plasmid mixed solution (DNA amount 10 μg) obtained in Example 2, pACYC177, an Escherichia coli drug-resistant vector (kanamycin resistance and ampicillin resistance; Journal of Bacteriology, 134
(3), 1141-1156, 1978) plasmid obtained from Escherichia coli C600
Add pACYC177 (shown in Figure 3; DNA amount: 2 μg) and react with at least a 5-fold excess of the restriction enzyme Xho using a conventional method under optimal conditions. After the reaction is complete, add an equal amount of phenol and stir vigorously. After inactivating the restriction enzymes, ether extraction was performed sufficiently to remove phenol, and twice the volume of ethanol was added and the mixture was kept at -80°C for 1 hour.
The DNA was precipitated by centrifugation at 15,000 rpm for 5 minutes, and the ethanol was removed by vacuum drying. Next, the precipitate was dissolved in water, and then T4 was added using a conventional method.
The DNA ligase reaction was carried out at 21°C for 2 hours, and the precipitate obtained by ethanol precipitation and vacuum drying was added to 0.1 ml of TE buffer in the same manner as above.
A solution containing the chimeric plasmid was obtained.

それぞれのキメラプラスミドはいずれもプラス
ミドpACYA177を含有している。しかし、プラ
スミドpACYA177のカナマイシン耐性部位に
Xho切断点があつて、そこが切断されているた
めにカナマイシン耐性は発現せず、アンピシリン
耐性のみが発現することになる。
Each chimeric plasmid contains plasmid pACYA177. However, the kanamycin resistance site of plasmid pACYA177
Since there is an Xho cleavage point and it is cleaved at that point, kanamycin resistance will not be expressed, and only ampicillin resistance will be expressed.

次の実施例1で得られたDNA受容菌体懸濁液
0.2mlを用意し、これに上記それぞれのキメラプ
ラスミド含有溶液を加え、0℃で90分間ゆるやか
に攪拌しつつ、キメラプラスミドの直接導入を行
なつた。
DNA receptor cell suspension obtained in the following Example 1
A 0.2 ml volume was prepared, each of the chimera plasmid-containing solutions mentioned above was added thereto, and the chimera plasmid was directly introduced while gently stirring at 0°C for 90 minutes.

ここに得られたキメラプラスミド導入菌体を含
む液を3mlのYPG培地に移し、30℃、6時間振
とう培養を行なつた後、アンピシリン50μg/ml
添加したYPG培地(固体)上で30℃で5日間培
養し、9株のコロニーを得た。これらを10−
80S1−A1〜−A9TOと命名した。このうち、10
−80S1−A1をアンピシリンを30μg/ml添加した
YPG液体培地で30℃、24時間振とう培養し、実
施例2の方法に従ってプラスミドを分離して解析
したところ、プラスミドpTA5001(A)とプラスミ
ドpTA5001(B)の混在物以外にこれらよりやや分
子量の大きいプラスミドが得られた。このプラス
ミドは先に導入したキメラプラスミドにうち、
pTA5001(A)とpACYA177がXho切断部位を介
して連結したキメラプラスミドと認められた。ま
た、アセトバクター・アセチ10−80S1はアンピ
シリン耐性を有しないが10−80S1−A1はアンピ
シリン耐性を持つていることなどからもキメラプ
ラスミドが導入され、形質転換が行なわれたこと
が確認された。
The resulting solution containing the chimeric plasmid-introduced bacterial cells was transferred to 3 ml of YPG medium, cultured with shaking at 30°C for 6 hours, and then supplemented with ampicillin at 50 μg/ml.
The cells were cultured on the added YPG medium (solid) at 30°C for 5 days, and 9 colonies were obtained. These are 10−
They were named 80S1-A1~-A9TO. Of these, 10
-80S1-A1 with ampicillin added at 30μg/ml
When cultured in a YPG liquid medium with shaking at 30°C for 24 hours, the plasmids were separated and analyzed according to the method of Example 2. A large plasmid was obtained. This plasmid is different from the previously introduced chimeric plasmid.
It was recognized as a chimeric plasmid in which pTA5001(A) and pACYA177 were linked via the Xho cleavage site. Furthermore, the fact that Acetobacter aceti 10-80S1 does not have ampicillin resistance, but 10-80S1-A1 does have ampicillin resistance, confirms that the chimeric plasmid was introduced and transformation was performed.

同様にして、少なくとも10−80S1−A2〜−A6
はpTA5001(B)とpACYA177が制限酵素Xho切
断部位を介して連結したキメラプラスミドが導入
されていることが確認された。
Similarly, at least 10−80S1−A2 to −A6
It was confirmed that a chimeric plasmid in which pTA5001(B) and pACYA177 were linked via the restriction enzyme Xho cleavage site had been introduced.

また、10−80S1−A1〜−A6の持つキメラプラ
スミドを再度10−80S1に前記と同様の方法で導
入したところ10−80S1−A1〜−A6の各キメラプ
ラスミドにおいて、1μgDNA量当りに換算して
105個前後のアンピシリン耐性の形質転換株が得
られた。
In addition, when the chimeric plasmids of 10-80S1-A1 to -A6 were reintroduced into 10-80S1 in the same manner as described above, the amount of chimeric plasmids of 10-80S1-A1 to -A6 was calculated per 1 μg DNA.
Approximately 10 5 ampicillin-resistant transformants were obtained.

【図面の簡単な説明】[Brief explanation of drawings]

第1図はプラスミドpTA5001(A)の制限酵素開
裂地図を示し、第2図はプラスミドpTA5001(B)
の制限酵素開裂地図を示し、第3図はプラスミド
pACYC177の制限酵素開裂地図を示す。 E……EcoRによる切断部位、S……Salに
よる切断部位、X……Xhoによる切断部位、
Km……カナマイシン耐性遺伝子、Am……アン
ピシリン耐性遺伝子。
Figure 1 shows the restriction enzyme cleavage map of plasmid pTA5001(A), and Figure 2 shows the restriction enzyme cleavage map of plasmid pTA5001(B).
Figure 3 shows the restriction enzyme cleavage map of the plasmid.
The restriction enzyme cleavage map of pACYC177 is shown. E...EcoR cleavage site, S...Sal cleavage site, X...Xho cleavage site,
Km...Kanamycin resistance gene, Am...Ampicillin resistance gene.

Claims (1)

【特許請求の範囲】 1 22.5Kbの分子量で、下記の制限酵素地図で
示されるプラスミドpTA5001(B)。 E:EcoR:Escherichia coli RY13 給源の制限酵素 S:Sal:Streptomyces albus G 給源の制限酵素 X:Xho:Xanthomonas holcicola 給源の制限酵素。
[Claims] 1. Plasmid pTA5001(B), which has a molecular weight of 22.5 Kb and is shown in the restriction enzyme map below. E: EcoR: Escherichia coli RY13 source restriction enzyme S: Sal: Streptomyces albus G source restriction enzyme X: Xho: Xanthomonas holcicola source restriction enzyme.
JP25431490A 1983-06-29 1990-09-26 Plasmid pta 5001 (b) Granted JPH03151881A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25431490A JPH03151881A (en) 1983-06-29 1990-09-26 Plasmid pta 5001 (b)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58116149A JPS609488A (en) 1983-06-29 1983-06-29 Vector of acetic acid bacteria
JP25431490A JPH03151881A (en) 1983-06-29 1990-09-26 Plasmid pta 5001 (b)

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP58116149A Division JPS609488A (en) 1983-06-29 1983-06-29 Vector of acetic acid bacteria

Publications (2)

Publication Number Publication Date
JPH03151881A JPH03151881A (en) 1991-06-28
JPH0371115B2 true JPH0371115B2 (en) 1991-11-12

Family

ID=26454519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25431490A Granted JPH03151881A (en) 1983-06-29 1990-09-26 Plasmid pta 5001 (b)

Country Status (1)

Country Link
JP (1) JPH03151881A (en)

Also Published As

Publication number Publication date
JPH03151881A (en) 1991-06-28

Similar Documents

Publication Publication Date Title
FI64813C (en) FOERFARANDE FOER PRODUCERING AV ETT UTVALT AEGGVITEAEMNE OCH VID FOERFARANDET ANVAENDA REKOMBINANTPLASMIDVEKTORER
JPH0363356B2 (en)
Valla et al. The plasmids of Acetobacter xylinum and their interaction with the host chromosome
JPH0669368B2 (en) Method for transforming acetic acid bacterium
JPH0371115B2 (en)
JPH0763371B2 (en) RNA polymerase gene and microorganisms carrying the gene
EP0374771B1 (en) Production method for PvuI restriction endonuclease
JP2857886B2 (en) A Bacillus sp. DNA fragment containing an L-lactate dehydrogenase gene and a recombinant plasmid containing the same, and an L-lactate dehydrogenase gene and a recombinant plasmid containing the same.
JP2833793B2 (en) Plasmid encoding heparinase, heparinase-producing strain carrying this plasmid, and method for producing heparinase
JP2518051B2 (en) Method for producing AccI restricted endonuclease
JPS60188069A (en) Transduction of cyclic dna into acetobacter
JP2728784B2 (en) Acetic acid bacterium, plasmid derived from the acetic acid bacterium, and shuttle vector constructed from the plasmid
JP2634606B2 (en) Plasmid pBY503
JPH0322154B2 (en)
JPS6235757B2 (en)
JP2651811B2 (en) Novel Escherichia coli having oligo-1,6-glucosidase gene and method for producing oligo-1,6-glucosidase
JPH0679556B2 (en) Plasmid
JP2904437B2 (en) DNA fragment containing sucrose phosphorylase gene
JP3107402B2 (en) Circular plasmid
JP2671008B2 (en) DNA encoding cyclomaltodextrin glucenotransferase, recombinant plasmid containing the same, and transformed microorganism containing the plasmid
SU1532585A1 (en) Recombinant plasmide dna encoding methylase sso ii, and strain of escherichia coli bakteria as producer of methylase sso ii
JPS60188068A (en) Transformation of acetobacter using drug-resistant gene
Ksënzenko et al. Specific fragmentation of DNA heteroduplex molecules of two bacteriophage λ mutants with endonucleaseSI from Aspergillus oryzae
JPH0440896A (en) New recombinant dna and production of sucrose-phosphorylase
JPH0322155B2 (en)